Q2 Solutions Company Market Research Report
Company Overview
Name: Q2 Solutions
Mission: Q2 Solutions aims to improve patient lives by treating each sample as if a life depends on it.
Founded: 2015
Founders: No information is available.
Key People:
- Brian O’Dwyer - Chief Executive Officer
- Kellie Yarnell - Chief Commercial Officer
- Patrice Hugo, Ph.D. - Chief Scientific Officer
- Kevin Dooley - Chief Human Resources Officer
- David Morris - Senior Vice President & Chief Operating Officer
- Caroline Keane - Senior Vice President, Integrated Laboratory Services
- Tony Brown - Vice President & General Manager, Specialty Laboratories Division
- Elaine Lowey - Vice President & General Manager, Global Central Labs
- Jenny Zhang - Vice President & General Manager, Asia-Pacific Operations
- David Kaye - Vice President & General Manager, BioFortis
- Ralph L. McDade, Ph.D. - Vice President & General Manager, Rules-Based Medicine (RBM)
- Pat Hurban - Vice President & General Manager, Genomics Laboratories
- Chuck Drucker - Vice President, Strategy and Corporate Development
- Simon Thornley - Vice President, Quality and Compliance
- Mike Hamill - Vice President, Information Technology
- Jian Wang - Vice President, Head of Digital Innovation
- Darlene Godsey - Senior Director, Business Operations
Headquarters: Durham, North Carolina, USA
Number of Employees: 1,001-5,000 employees
Revenue: No information is available.
Company Known For: Q2 Solutions is known for drug discovery and development laboratory services, encompassing ADME, bioanalytical, genomics, immunoassay testing, vaccines, antibody drug discovery, and central laboratory services, including flow cytometry, anatomic pathology, molecular and companion diagnostics, and decentralized clinical trials.
Products
Central Laboratory Services
- Description: Comprehensive testing and management services supporting clinical trials.
- Key Features:
- Flow Cytometry
- Anatomic Pathology
- Molecular diagnostics
- Decentralized clinical trials
Bioanalytical Laboratory Services
- Description: Specialized services in large and small molecule bioanalysis.
- Key Features:
- Ligand Binding Assays
- Mass Spectrometry
- Immunoassays
ADME/DMPK Services
- Description: Support for absorption, distribution, metabolism, and excretion studies.
- Key Features:
- Metabolic stability
- Protein binding studies
- Metabolite profiling
Genomic Laboratory Services
- Description: Genetic testing and molecular diagnostics.
- Key Features:
- DNA and RNA sequencing
- Targeted biomarker testing
- Bioinformatics
Vaccine Laboratory Services
- Description: Services specialized in testing and development of vaccines.
- Key Features:
- Immunogenicity testing
- Vaccine efficacy monitoring
- Assay technology transfer
Translational Science and Innovation Laboratory (TSAIL)
- Description: Supports advanced laboratory capabilities for drug development.
- Key Features:
- Biomarker discovery
- Genomics and bioanalytical sciences
- AI/ML integration for analytics
Biorepository and Specimen Management
- Description: Management of biological specimen storage and logistics.
- Key Features:
- Secure specimen storage
- Specimen tracking
- Global logistics support
BioFortis Clinical Trial Sample and Consent Tracking
- Description: Sample and consent tracking platform for clinical trials.
- Key Features:
- Real-time tracking
- 21 CFR Part 11 compliance
- Enhanced data integrity
Recent Developments
New Products Launched
- TruSight Oncology 500 (TSO500) Tissue Assay:
- Description: A cancer panel designed for genomic profiling.
- Key Features: Targets 523 genes, detects a wide array of genetic alterations, evaluates tumor mutational burden (TMB) and microsatellite instability (MSI), and offers comprehensive genomic profiling validated for CAP/CLIA compliance.
- My Green Lab Certification:
- Location: Q2 Solutions Scotland-based Central Laboratory.
- Impact: Recognized by the United Nations Race to Zero (Carbon) campaign.
New Features Added to Existing Products
- Anatomical Pathology ePROC and ePRF:
- Description: Enhanced with completely digitized solutions.
- Key Features: Paperless workflow, direct electronic data capture, real-time data entry, and workflow management.
- Flow Cytometry Automation:
- Description: Automated calculations to eliminate manual errors.
- Key Features: Electronic audit trail, real-time QC monitoring, increased data generation with Cytek™ Aurora platform.
New Partnerships
- Specifica Antibody Discovery Platform Transfer Agreement with Servier and Subsidiary Symphogen:
- Description: Transfer of a new antibody discovery platform.
- Impact: Expands Specifica’s library offerings and capabilities for therapeutic antibody discovery.
- CEPI Partnership:
- Description: Q² Solutions Beijing joins the global network of COVID-19 vaccine testing labs.
- Impact: Contributes to the global effort in COVID-19 vaccine testing.
Conclusion
Q2 Solutions, under the guidance of an experienced leadership team, has established itself as a leader in drug discovery and development laboratory services. The company offers a broad spectrum of innovative solutions including genomic, bioanalytical, and vaccine testing services. Their recent developments show a strong commitment to sustainability, digital innovation, and expansion through strategic partnerships, positioning Q2 Solutions to continue driving forward advancements in healthcare.
Note: No additional commentary is provided as per the instructions.